Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome

References

1. ↵
   Winick NJ, Bowman WP, Kamen BA, et al. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992;84:252–256

   Abstract/FREE Full Text
2. ↵
   Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association between intermediate–dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712–1722

   Abstract
3. ↵
   Winick N, Shuster JJ, Bowman WP, et al. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol 1996;14:2803–2811

   Abstract/FREE Full Text
4. ↵
   Rubnitz JE, Relling MV, Harrison, et al. Transient leukoencephalopathy following high dose methotrexate treatment in childhood acute lymphocytic leukemia. Leukemia 1998;12:1176–1181

   CrossRefPubMedWeb of Science
5. ↵
   Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975;35:291–305

   CrossRefPubMedWeb of Science
6. ↵
   Ebner F, Ranner G, Slavc I, et al. MR findings in methotrexate-induced CNS abnormalities. AJNR Am J Neuroradiol 1989;10:959–964

   Abstract/FREE Full Text
7. ↵
   Davidson A, Payne G, Leach MO, et al. Proton magnetic resonance spectroscopy of the brain following high-dose methotrexate therapy for childhood cancer. Med Pediatr Oncol 2000;35:28–34

   CrossRefPubMed
8. ↵
   Komatsu K, Takada G, Uemura K, Shisido F, Kanno I. Decrease in cerebral metabolic rate of glucose after high dose methotrexate in childhood acute lymphocytic leukemia. Pediatric Neurol 1990;6:303–306

   CrossRefPubMedWeb of Science
9. ↵
   Kishi S, Greiner J, Cheng C, et al. Homocysteine, pharmacokinetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003;15:3084–3091
10. ↵
    Mizuasawa S, Kondoh Y, Murakami M, et al. Effect of methotrexate on local cerebral blood flow in conscious rats. Jpn J Pharmacol 1988;48:499–501

    PubMed
11. ↵
    Harila-Saari AH, Ahonen AKA, Vainionpaa LK, et al. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. J Nucl Med 1977;38:82–88
12. ↵
    Provenzale JM, Jahan R, Naidich TP, Fox AJ. Assessment of the patient with hyperacute stroke: imaging and therapy. Radiology 2003;229:347–359

    PubMedWeb of Science
13. ↵
    Provenzale JM, Sorensen AG. Diffusion-weighted MR imaging in acute stroke: theoretical considerations and clinical applications. AJR Am J Roentgenol 1999;173:1459–1468

    CrossRefPubMedWeb of Science
14. ↵
    Rovira A, Rovira-Gols A, Pedraza S, et al. Diffusion-weighted imaging in the acute phase of transient ischemic attacks. AJNR Am J Neuroradiol 2002;23:77–83

    Abstract/FREE Full Text
15. ↵
    Yaffe K, Ferreiro D, Barkovich JA, Rowley H. Reversible MRI abnormalities following seizures. Neurology 1995;45:104–107

    Abstract/FREE Full Text
16. ↵
    Paako E, Harila-Saari AH, Vainionpaa LK, Himanen S, Pyhtinen J, Lanning M. White matter changes on MR during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol 2000;35:456–461

    CrossRefPubMedWeb of Science
17. ↵
    Paako E, Vainionpaa LK, Pyhtinen J, Lanning M. Minor changes on cranial MRI during treatment in children with acute lymphocytic leukemia. Neuroradiology 1996;38:264–268

    PubMedWeb of Science
18. ↵
    Chen C-Y, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Malloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996;17:295–310

    Abstract
19. ↵
    Sandoval C, Kutscher M, Jayabose S, Tenner M. Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol 2003;24:1887–1890

    Abstract/FREE Full Text
20. ↵
    Kirshner HS. Language disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice. 2nd ed. Boston: Butterworth-Heinemann;1996 :140–141
21. ↵
    Shin RK, Stern JW, Janss AJ, et al. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001;56:388–391

    Abstract/FREE Full Text